Journey Medical Corp. (DERM)
6.14
-0.18
(-2.85%)
USD |
NASDAQ |
Sep 25, 16:00
6.14
0.00 (0.00%)
After-Hours: 19:59
Journey Medical Research and Development Expense (Annual) : 0.48M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.48M |
| December 31, 2024 | 9.857M |
| December 31, 2023 | 7.541M |
| December 31, 2022 | 10.94M |
| Date | Value |
|---|---|
| December 31, 2021 | 16.56M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 117.07M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |
| Johnson & Johnson | 14.83B |